Travere Therapeutics Announces Proposed Public Offering of Common Stock

SAN DIEGO , Nov. 07, 2024 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that it intends to offer and sell, in an underwritten public offering and subject to market and other conditions, shares of its common stock. All of the shares are being offered by Travere.